Glenmark Pharma receives ANDA approval for Rosuvastatin calcium tablets

Glenmark Pharmaceuticals Inc USA has been granted final approval by the USFDA for Rosuvastatin Calcium Tablets, 5 mg (base), 10 mg (base), 20 mg (base), and 40 mg (base), the generic version of Crestor tablets, 5 mg, 10 mg, 20 mg, and 40 mg of IPR Pharmaceuticals Inc.

July 20, 2016 / 08:55 IST

26 Aug, 2025 12:21

Volume

Todays L/H

Glenmark Pharmaceuticals Ltd has informed BSE regarding a Press Release dated July 20, 2016, titled "Glenmark Pharmaceuticals receives ANDA approval for Rosuvastatin Calcium Tablets, 5 mg (base), 10 mg (base), 20 mg (base), and 40 mg (base)".Source : BSE

Read all announcements in Glenmark

first published: Jul 20, 2016 08:55 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347